G418
G418 is an aminoglycoside antibiotic similar in structure to gentamicin. It is produced by the bacterium Micromonospora rhodorangea. G418 blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells. In molecular biology, it is used as a selective agent to identify cells that have been successfully genetically modified using the neomycin resistance gene (Neo^R), which provides resistance to G418.
History[edit | edit source]
G418 was first isolated in the 1970s from the bacterium Micromonospora rhodorangea. It was initially used as an antibiotic in veterinary medicine, but its use in molecular biology research has since become more prevalent.
Mechanism of Action[edit | edit source]
G418 inhibits protein synthesis by binding to the ribosome, specifically the 30S ribosomal subunit, and causing misreading of the mRNA template. This results in the production of non-functional or toxic peptides, leading to cell death.
Use in Molecular Biology[edit | edit source]
In molecular biology, G418 is used as a selective agent to identify cells that have been successfully genetically modified. The neomycin resistance gene (Neo^R) is often included in the DNA construct that is introduced into the cells. This gene codes for an aminoglycoside phosphotransferase enzyme that can inactivate G418 by phosphorylation. Cells that have incorporated the Neo^R gene into their genome will be resistant to G418, while non-transformed cells will be sensitive to the antibiotic and will die.
Safety and Toxicity[edit | edit source]
Like other aminoglycoside antibiotics, G418 can be toxic to humans. It can cause damage to the kidneys and the auditory nerve, leading to nephrotoxicity and ototoxicity, respectively. Therefore, it should be handled with care in the laboratory.
See Also[edit | edit source]
| This article is a stub. You can help WikiMD by registering to expand it. |
This Molecular Biology related article is a stub. You can help WikiMD by expanding it.
 | This genetics article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
